News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
171,242 Results
Type
Article (31819)
Company Profile (11)
Press Release (139412)
Multimedia
Podcasts (4)
Webinars (9)
Section
Business (52013)
Career Advice (364)
Deals (3226)
Drug Delivery (8)
Drug Development (23854)
Employer Resources (32)
FDA (3322)
Job Trends (3176)
News (80395)
Policy (4165)
Tag
Academia (2400)
Academic (1)
Accelerated approval (2)
Adcomms (7)
Allergies (20)
Alliances (10872)
ALS (27)
Alzheimer's disease (523)
Antibody-drug conjugate (ADC) (21)
Approvals (3349)
Artificial intelligence (54)
Autoimmune disease (1)
Automation (4)
Bankruptcy (18)
Best Places to Work (2666)
BIOSECURE Act (3)
Biosimilars (8)
Biotechnology (13)
Bladder cancer (24)
Brain cancer (9)
Breast cancer (86)
Cancer (633)
Cardiovascular disease (40)
Career advice (337)
Career pathing (9)
CAR-T (44)
Cell therapy (113)
Cervical cancer (6)
Clinical research (18548)
Collaboration (165)
Compensation (9)
Complete response letters (1)
COVID-19 (1175)
CRISPR (12)
C-suite (152)
Cystic fibrosis (23)
Data (752)
Decentralized trials (1)
Denatured (3)
Depression (6)
Diabetes (55)
Diagnostics (1655)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (23)
Drug pricing (7)
Drug shortages (1)
Duchenne muscular dystrophy (20)
Earnings (6309)
Editorial (6)
Employer branding (2)
Employer resources (29)
Events (17662)
Executive appointments (463)
FDA (3573)
Frontotemporal dementia (4)
Funding (201)
Gene editing (32)
Generative AI (3)
Gene therapy (77)
GLP-1 (125)
Government (941)
Guidances (3)
Healthcare (5091)
Huntington's disease (2)
IgA nephropathy (8)
Immunology and inflammation (10)
Indications (9)
Infectious disease (1208)
Inflammatory bowel disease (41)
Inflation Reduction Act (1)
Influenza (16)
Intellectual property (18)
Interviews (41)
IPO (1467)
IRA (6)
Job creations (574)
Job search strategy (315)
Kidney cancer (5)
Labor market (6)
Layoffs (33)
Leadership (2)
Legal (680)
Liver cancer (21)
Lung cancer (84)
Lymphoma (48)
Machine learning (2)
Management (9)
Manufacturing (38)
MASH (24)
Medical device (3030)
Medtech (3031)
Mergers & acquisitions (1811)
Metabolic disorders (120)
Multiple sclerosis (19)
NASH (5)
Neurodegenerative disease (26)
Neuropsychiatric disorders (1)
Neuroscience (649)
NextGen: Class of 2025 (1790)
Non-profit (1696)
Now hiring (4)
Obesity (40)
Opinion (29)
Ovarian cancer (30)
Pain (15)
Pancreatic cancer (28)
Parkinson's disease (39)
Partnered (4)
Patents (40)
Patient recruitment (34)
Peanut (12)
People (32311)
Phase I (5911)
Phase II (8500)
Phase III (5641)
Pipeline (191)
Policy (21)
Postmarket research (955)
Preclinical (3071)
Press Release (25)
Prostate cancer (28)
Psychedelics (8)
Radiopharmaceuticals (66)
Rare diseases (91)
Real estate (1272)
Recruiting (15)
Regulatory (2972)
Reports (3)
Research institute (1349)
Resumes & cover letters (23)
Rett syndrome (2)
RNA editing (1)
RSV (1)
Schizophrenia (9)
Series A (30)
Series B (20)
Sickle cell disease (16)
Spinal muscular atrophy (38)
Sponsored (6)
Startups (1107)
Stomach cancer (1)
Tariffs (3)
The Weekly (1)
Vaccines (204)
Venture capitalists (1)
Weight loss (22)
Women's health (6)
Worklife (2)
Date
Today (13)
Last 7 days (194)
Last 30 days (604)
Last 365 days (7036)
2025 (2242)
2024 (7504)
2023 (9278)
2022 (11522)
2021 (13272)
2020 (12749)
2019 (12108)
2018 (8990)
2017 (8685)
2016 (8890)
2015 (10200)
2014 (7788)
2013 (7577)
2012 (7526)
2011 (7541)
2010 (6761)
Location
Africa (262)
Alabama (11)
Alaska (3)
Arizona (38)
Arkansas (6)
Asia (10392)
Australia (2612)
California (1353)
Canada (419)
China (103)
Colorado (60)
Connecticut (66)
Delaware (30)
Europe (27987)
Florida (161)
Georgia (48)
Idaho (12)
Illinois (125)
India (3)
Indiana (61)
Iowa (2)
Japan (49)
Kansas (13)
Kentucky (4)
Louisiana (1)
Maine (13)
Maryland (149)
Massachusetts (897)
Michigan (38)
Minnesota (69)
Mississippi (1)
Missouri (20)
Montana (6)
Nebraska (4)
Nevada (13)
New Hampshire (8)
New Jersey (381)
New Mexico (8)
New York (393)
North Carolina (263)
North Dakota (2)
Northern California (646)
Ohio (67)
Oklahoma (5)
Oregon (9)
Pennsylvania (270)
Puerto Rico (1)
Rhode Island (12)
South America (288)
South Carolina (3)
Southern California (501)
Tennessee (25)
Texas (200)
United States (4927)
Utah (42)
Virginia (34)
Washington D.C. (18)
Washington State (140)
West Virginia (1)
Wisconsin (11)
171,242 Results for "utrecht university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Medera’s Novoheart Expands Human Cardiac Research with CTScreen™ Installation at University Medical Center, Utrecht
February 10, 2025
·
14 min read
Business
Ractigen Therapeutics Enters Strategic Partnership with University Medical Center Utrecht to Drive saRNA Innovation in Neurodevelopmental Disorders
Ractigen Therapeutics announces a formal collaboration with University Medical Center Utrecht, affiliated with Utrecht University.
January 29, 2024
·
2 min read
Press Releases
UMC Utrecht adopts Volta Labs Callisto Sample Prep System to process thousands of samples for Whole Genome Sequencing-based prenatal and postnatal testing
February 6, 2025
·
3 min read
Business
Artizan Biosciences Announces Multi-Year Research Collaboration with the University Medical Center Utrecht and Microviable Therapeutics
Artizan Biosciences, Inc. today announced that it has entered into a multi-year research collaboration with the University Medical Center Utrecht (“UMC Utrecht”) in The Netherlands and Microviable Therapeutics.
July 21, 2022
·
5 min read
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University
Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.
March 11, 2024
·
3 min read
Layoffs
Astellas Cuts 24 Universal Cells Roles in Seattle, Transfers 12 to Japan
Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.
October 10, 2024
·
1 min read
·
Angela Gabriel
Biotech Beach
Professor René Bernards to Present New Pre-Clinical Data on LIXTE’s LB-100 at Joint Conference of European and American Associations for Cancer Research
LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT and LIXTW) (“LIXTE” or the “Company”) today announced that René Bernards, PhD, professor of molecular carcinogenesis at Utrecht University in Amsterdam and head of molecular carcinogenesis at the Netherlands Cancer Institute, will present new pre-clinical data on LIXTE’s lead compound, LB-100, at the Joint Conference of European and American Associations for Cancer Research this week in Dublin, Ireland.
February 27, 2024
·
4 min read
Genetown
Utrecht University and Bruker Announce Collaboration to Develop Methods for Studying Protein Structures and Interactions by Mass Spectrometry
Bruker Corporation (Nasdaq: BRKR) today announced a collaboration with Utrecht University to advance the study of the 3-D structures and interactions of proteins by mass spectrometry.
August 7, 2020
·
5 min read
Drug Development
Harbour BioMed and Utrecht University Announce License Agreement with AbbVie and Initiation of COVID-19 Antibody Clinical Trials
Harbour BioMed (HBM)(HKEX:02142), and Utrecht University (UU) today announced that they licensed to AbbVie their fully human, SARS-CoV-2 neutralizing antibody, 47D11 and program, for the prevention and treatment of COVID-19 and related coronaviruses, and that AbbVie has initiated a Phase 1 clinical trial of the antibody
December 14, 2020
·
3 min read
Press Releases
LIfT BioSciences announces partnership with University of Galway for clinical trial in Ireland
April 28, 2025
·
4 min read
1 of 17,125
Next
